BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 14767651)

  • 1. Applicability of American and British criteria for screening of the retinopathy of prematurity in Thailand.
    Trinavarat A; Atchaneeyasakul LO; Udompunturak S
    Jpn J Ophthalmol; 2004; 48(1):50-3. PubMed ID: 14767651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adequacy of published screening criteria for retinopathy of prematurity.
    Taranath DA; Oh DD; Keane MC; Fabel H; Marshall P
    Clin Exp Ophthalmol; 2016 Mar; 44(2):121-7. PubMed ID: 26251888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinopathy of prematurity screening criteria in Iran: new screening guidelines.
    Roohipoor R; Karkhaneh R; Farahani A; Ebrahimiadib N; Modjtahedi B; Fotouhi A; Yaseri M; Khodabande A; Zarei M; Imani Fuladi M; Taheri A; Riazi Esfahani M; Loewenstein J
    Arch Dis Child Fetal Neonatal Ed; 2016 Jul; 101(4):F288-93. PubMed ID: 27073259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for retinopathy of prematurity in China: a neonatal units-based prospective study.
    Xu Y; Zhou X; Zhang Q; Ji X; Zhang Q; Zhu J; Chen C; Zhao P
    Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8229-36. PubMed ID: 24204053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinopathy of prematurity: are we screening too many babies?
    Mathew MR; Fern AI; Hill R
    Eye (Lond); 2002 Sep; 16(5):538-42. PubMed ID: 12194065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANALYSIS OF CHANGES IN CHARACTERISTICS OF SEVERE RETINOPATHY OF PREMATURITY PATIENTS AFTER SCREENING GUIDELINES WERE ISSUED IN CHINA.
    Chen Y; Feng J; Li F; Yin H; Liang J; Li X
    Retina; 2015 Aug; 35(8):1674-9. PubMed ID: 25719989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proposal of screening guideline for retinopathy of prematurity in Taiwan.
    Chiang MC; Tang JR; Yau KI; Yang CM
    Acta Paediatr Taiwan; 2002; 43(4):204-7. PubMed ID: 12238908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinopathy of prematurity: are we missing any infant with retinopathy of prematurity?
    Amer M; Jafri WH; Nizami AM; Shomrani AI; Al-Dabaan AA; Rashid K
    Br J Ophthalmol; 2012 Aug; 96(8):1052-5. PubMed ID: 22649086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of new guidelines for ROP screening in Sweden using SWEDROP - a national quality register.
    Holmström G; Hellström A; Jakobsson P; Lundgren P; Tornqvist K; Wallin A
    Acta Ophthalmol; 2015 May; 93(3):265-8. PubMed ID: 25044161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Modified Screening Criteria for Retinopathy of Prematurity: Primary Results From the Postnatal Growth and Retinopathy of Prematurity Study.
    Binenbaum G; Bell EF; Donohue P; Quinn G; Shaffer J; Tomlinson LA; Ying GS;
    JAMA Ophthalmol; 2018 Sep; 136(9):1034-1040. PubMed ID: 30003216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinopathy of prematurity: an evaluation of existing screening criteria in Pakistan.
    Chaudhry TA; Hashmi FK; Salat MS; Khan QA; Ahad A; Taqui AM; Syed R; Ahmad K
    Br J Ophthalmol; 2014 Mar; 98(3):298-301. PubMed ID: 24344233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should fewer premature infants be screened for retinopathy of prematurity in the managed care era?
    Wright K; Anderson ME; Walker E; Lorch V
    Pediatrics; 1998 Jul; 102(1 Pt 1):31-4. PubMed ID: 9651410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinopathy of prematurity: an optimum screening strategy.
    Ho SF; Mathew MR; Wykes W; Lavy T; Marshall T
    J AAPOS; 2005 Dec; 9(6):584-8. PubMed ID: 16414528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do current retinopathy of prematurity screening guidelines miss the early development of pre-threshold type 1 ROP in small for gestational age neonates?
    Misra A; Heckford E; Curley A; Allen L
    Eye (Lond); 2008 Jun; 22(6):825-9. PubMed ID: 17293789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe retinopathy of prematurity: longitudinal observation of disease and screening implications.
    Ells A; Hicks M; Fielden M; Ingram A
    Eye (Lond); 2005 Feb; 19(2):138-44. PubMed ID: 15218516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening for retinopathy of prematurity--qualification criteria on the basis of our experience].
    Hautz W; Grałek M; Dobrzańska A; Trzebicka A
    Klin Oczna; 2006; 108(7-9):316-8. PubMed ID: 17290832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening criteria for retinopathy of prematurity in developing countries.
    Akman I; Demirel U; Yenice O; Ilerisoy H; Kazokoğlu H; Ozek E
    Eur J Ophthalmol; 2010; 20(5):931-7. PubMed ID: 20383846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinopathy of prematurity in Saudi Arabia: incidence, risk factors, and the applicability of current screening criteria.
    Binkhathlan AA; Almahmoud LA; Saleh MJ; Srungeri S
    Br J Ophthalmol; 2008 Feb; 92(2):167-9. PubMed ID: 18227198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Colorado-retinopathy of prematurity model (CO-ROP): postnatal weight gain screening algorithm.
    Cao JH; Wagner BD; McCourt EA; Cerda A; Sillau S; Palestine A; Enzenauer RW; Mets-Halgrimson RB; Paciuc-Beja M; Gralla J; Braverman RS; Lynch A
    J AAPOS; 2016 Feb; 20(1):19-24. PubMed ID: 26917066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Criteria.
    Binenbaum G; Tomlinson LA; de Alba Campomanes AG; Bell EF; Donohue P; Morrison D; Quinn GE; Repka MX; Rogers D; Yang MB; Yu Y; Ying GS;
    JAMA Ophthalmol; 2020 Jan; 138(1):31-37. PubMed ID: 31725856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.